Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Method-for-treating-diseases-of-the-inner-ear-using-adamantane-derivatives

 Modified HIL-6
OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group ...


 Construction of geometrical objects from polynucleotides
By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a ...


 Starburst conjugates
In its broadest aspect, the present invention is directed to polymer conjugate materials comprising ...


 Intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected ...


 Antiviral polynucleotide conjugates
OF THE INVENTION The present invention provides polynucleotide conjugates characterized by the ...


 Azlactone activated polyalkylene oxides conjugated to biologically active nucleophiles
OF THE PREFERRED EMBODIMENT The azlactone activated polyalkylene oxides of the present invention ...


 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
INCLUSIVE OF PREFERRED EMBODIMENTS We have discovered that linear block copolymers comprising ...


 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
The present invention provides for compounds having the formula: ##STR1## wherein R.sub.1 is ...


 Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
OF THE INVENTION The following examples are given to illustrate the invention, but should not be ...


 Polyoxypropylene/polyoxyethylene copolmers with improved biological activity
Although the prior art preparations of polyoxypropylene/polyoxyethylene block copolymers may have ...


 Method for treating diseases of the inner ear using adamantane derivatives

Details
Inventors: Zenner, Hans Peter; Ruppersberg, J. Peter; Busch, Andreas;
Assignee: Tinnitus Forschungs-und Entwicklungs GmbH (Munich, DE)
Primary Examiner: Fay; Zohreh
Assistant Examiner:
Attorney, Agent or Firm: Pennie & Edmonds LLP

Use of adamantane derivatives of the formula ##STR1## in which R1 and R2 are identical or different and can be hydrogen or straight-chained or branched alkyl groups having 1 to 6 carbon atoms, or together with the nitrogen atom can represent a heterocyclic group having 5 or 6 ring atoms, in which R3 and R4 are identical or different and can be hydrogen, straight-chained or branched alkyl groups having between 1 and 6 carbon atoms, cycloalkyl groups having 5 or 6 carbon atoms or a phenyl group, and in which R5 is hydrogen or a straight-chained or branched alkyl group having between 1 and 6 carbon atoms for treating diseases of the inner ear.

DETAILED DESCRIPTION OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or conceivable in many cases of diseases of the inner ear.
Preferably, adamantane derivatives can be used in the case of inner ear diseases in which troublesome ear noise, so-called tinnitus occurs, especially in the case of treating such forms of tinnitus as chronic tinnitus, subacute tinnitus or also acute permanent tinnitus, since it is just these patients that require intensive therapy.
In addition to other inner ear diseases those in which tinnitus occurs often involving loss of hearing (deafness) are concerned.
In a tinnitus occurrence this loss of hearing lies in the frequency range of the tinnitus, the impaired hearing being associated with a so-called positive recruitment and/or (amplitude) reduction or failure of otoacoustic emissions.
The so-called positive recruitment is a phenomenon in audiometry when a comparison of the loudness is undertaken in the case of one-sided deafness.
In the case of positive recruitment a slight amplification is needed in the ear impaired in hearing to prompt the same loudness sensitivity as for the healthy ear, i.
e.
the loss in hearing is compensated by increasing loudness.
The so-called otoacoustic emissions are noise events occurring in the external canal having to do with the condition of the middle ear or inner ear.
Otoacoustic emissions may occur spontaneously, i.
e.
without the ear receiving external stimulation or also being evoked externally, for example with the aid of a sound emitter.
Both the occurrence of positive recruitment and the reduction or failure of otoacoustic emissions can be measured and thus an inner ear dysfunction assigned to the patients concerned.
Should a patient be inflicted simultaneously with a tinnitus and a reduction in hearing in the corresponding frequency range of the tinnitus associated with a positive recruitment and/or reduction or failure of otoacoustic emissions, it can be concluded that an impairement or dysfunction of the outer hair cells and its cochlear amplifier is involved



Related patents
  Polyalkylene oxide-containing urethane polyols with sulphonic acid groups
What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane polyols corresponding to the formula: ##STR16## wherein X represents an NH....
  Herpes treatment
I claim: 1. A method for the control of herpes virus infections in man which comprises contacting the herpes lesions, topically or by injection, with a dose of L-lysine L...
  Dense star polymers and dendrimers
OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is covalently bonded to at least one core branch, preferably at least two, ...
  Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is group U of ...
  Oligonucleotide derivatives and production thereof
Gist In view of the state of the art as described above, the present inventors have developed an immobilized oligonucleotide which is useful in purification of nucleic ...
  Process for synthesizing macrocyclic chelates
The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process involves condensing an amide of ethylene diamine having a general ...
  Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a predominant species, comprising the steps of: combining a protein selected ...
  Compositions for photodynamic therapy
I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains, as active ingredient, a conjugate of a porphyrin-type ...
  Amplifier molecules for enhancement of diagnosis and therapy
As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a multiplicity of terminal amine moieties, each serving as a locus to which one or ...
  Peptide-containing polyethylene glycol derivatives and application thereof
OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. The peptide-containing polyethylene glycol derivatives of the present ...

0.074

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved